Arete Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Arete Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,036	Closed	-$227M	–	659
2022 Q4	$227M	Buy	8,036 +820	+11%	+$26K	0.02%	530
2022 Q3	$237K	Buy	7,216 +281	+4%	+$10.3K	0.02%	474
2022 Q2	$219K	Buy	6,935 +159	+2%	+$5.56K	0.02%	410
2022 Q1	$311K	Sell	6,776 -746	-10%	-$35.6K	0.03%	368
2021 Q4	$473K	Buy	7,522 +328	+5%	+$22.7K	0.04%	296
2021 Q3	$538K	Sell	7,194 -58	-0.8%	-$4.87K	0.06%	246
2021 Q2	$519K	Buy	7,252 +319	+5%	+$27.1K	0.07%	200
2021 Q1	$615K	Sell	6,933 -9,969	-59%	-$989K	0.08%	210
2020 Q4	$1.57M	Buy	16,902 +415	+3%	+$33.1K	0.22%	101
2020 Q3	$1.04M	Buy	+16,487	New	+$966K	0.16%	147

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Arete Wealth Advisors's ARKG Position: Q1 2023 in Review

Arete Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 8,036 shares — an estimated $227M sold.

Arete Wealth Advisors first reported a position in ARKG in Q3 2020 and held it in 10 quarters. The position peaked at $227M in Q4 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Arete Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Arete Wealth Advisors sold 8,036 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $227M.
Arete Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 10 quarters.
Arete Wealth Advisors's ARK Genomic Revolution ETF position peaked at $227M in Q4 2022.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Arete Wealth Advisors's 13F filing for Q1 2023, filed 1 May 2023.